drugset / Trial / NCT03059537
Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea
NaSingle-groupOpen-labelDiagnostic
Summary
This study aims to validate a possible diagnostic test for bile acid diarrhoea prospectively compared to the SeHCAT scintigraphy. Fasting participants are given a standard meal and 1,250 mg chenodeoxycholic acid. The investigators measure fasting FGF19, bile acids species including 7-alpha-CHO and serial blood samples after the stimulation.
Timeline
- Start
- 2017-03-13
- Primary completion
- 2017-11-27
- Completion
- 2017-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chenodeoxycholic Acid | Small molecule | 1250 mg | Oral |